Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

BACKGROUND: Clinical experience with adenovirus vectors has highlighted the need for improved delivery and targeting. OBJECTIVE: This manuscript aims to provide an overview of the techniques currently under development for improving adenovirus delivery to malignant cells in vivo. METHODS: Primary research articles reporting improvements in adenoviral gene delivery are described. Strategies include genetic modification of viral coat proteins, non-genetic modifications including polymer encapsulation approaches and pharmacological interventions. RESULTS/CONCLUSION: Reprogramming adenovirus tropism in vitro has been convincingly demonstrated using a range of genetic and physical strategies. These studies have provided new insights into our understanding of virology and the field is progressing. However, there are still some limitations that need special consideration before adenovirus-targeted cancer gene therapy emerges as a routine treatment in the clinical setting.

Original publication

DOI

10.1517/17425240802507636

Type

Journal article

Journal

Expert Opin Drug Deliv

Publication Date

11/2008

Volume

5

Pages

1231 - 1240

Keywords

Adenoviridae, Amino Acid Sequence, Animals, Antibodies, Bispecific, Capsid Proteins, Disease Models, Animal, Genetic Therapy, Genetic Vectors, Humans, Mutant Chimeric Proteins, Neoplasms